United States: Yearly Stock Market Performance Insight - 2007

Yearly Gainers
900
Yearly Losers
1,217
Average Return
5.25%
Total Stocks
2,231
View Detailed Market Cap Breakdown
Market Cap Yearly Gainers Yearly Losers Average Return Total Stocks
Mega Cap 27 10 20.13% 38
Large Cap 291 201 13.55% 508
Mid Cap 204 282 1.76% 507
Small Cap 75 115 3.26% 202

Yearly Streak Leaders for 2007

Stock Streak Streak Return
7 years โ†‘ 87.97%

Procter & Gamble demonstrates exceptional long-term growth with a 7-year growth streak (39.06 โ†’ 73.42), delivering 88.0% cumulative returns. Annual financials validate this performance: 19.8B revenue generating 3.8B net profit (19.2% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025.

5 years โ†‘ 2,619.23%

Apple demonstrates exceptional long-term growth with a 5-year growth streak (0.26 โ†’ 7.07), delivering 2,619.2% cumulative returns. Annual financials validate this performance: 95.4B revenue generating 24.8B net profit (26.0% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025.

3 years โ†“ -37.33%

Home Depot navigates difficult years with a 3-year decline (42.99 โ†’ 26.94), down 37.3% cumulatively. Annual revenue of 39.9B provides stability, but 3.4B net income (8.6% margin) in Qtr ending Apr 2025 highlights operational challenges requiring strategic shifts.

2 years โ†“ -75.82%

Advanced Micro navigates difficult years with a 2-year decline (31.02 โ†’ 7.50), down 75.8% cumulatively. Weak margins on 7.4B annual revenue with only 709.0M profit (9.5% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before recovery.

14 years โ†‘ 4,653.19%

Expeditors continues its impressive multi-year expansion with a 14-year growth streak (0.94 โ†’ 44.68), delivering 4,653.2% cumulative returns. With 2.7B annual revenue generating only 204.1M profit (7.7% margin) in Qtr ending Mar 2025, the market prices in significant margin expansion ahead.

11 years โ†‘ 2,887.01%

Gilead Sciences solidifies its market leadership with a 11-year growth streak (0.77 โ†’ 23.00), delivering 2,887.0% cumulative returns. Annual financials validate this performance: 6.7B revenue generating 1.3B net profit (19.7% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025.

6 years โ†“ -87.06%

Tenet Healthcare endures extended market pressure with a 6-year decline (157.07 โ†’ 20.32), down 87.1% cumulatively. Weak margins on 5.2B annual revenue with only 622.0M profit (11.9% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before recovery.

4 years โ†“ -76.30%

Primo Brands faces prolonged challenges with a 4-year decline (28.10 โ†’ 6.66), down 76.3% cumulatively. Weak margins on 1.6B annual revenue with only 28.7M profit (1.8% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before recovery.

9 years โ†‘ 4,409.88%

Ssr Mining solidifies its market leadership with a 9-year growth streak (0.81 โ†’ 36.53), delivering 4,409.9% cumulative returns. Annual financials validate this performance: 316.6M revenue generating 54.4M net profit (17.2% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025.

9 years โ†‘ 3,265.00%

Penn Entertainment demonstrates exceptional long-term growth with a 9-year growth streak (0.40 โ†’ 13.46), delivering 3,265.0% cumulative returns. With 1.7B annual revenue generating only 111.5M profit (6.7% margin) in Qtr ending Mar 2025, the market prices in significant margin expansion ahead.

4 years โ†“ -85.46%

Sanmina struggles through multi-year headwinds with a 4-year decline (75.12 โ†’ 10.92), down 85.5% cumulatively. Weak margins on 2.0B annual revenue with only 70.5M profit (3.6% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before recovery.

4 years โ†“ -84.22%

Kratos Defense faces prolonged challenges with a 4-year decline (148.90 โ†’ 23.50), down 84.2% cumulatively. Weak margins on 302.6M annual revenue with only 4.5M profit (1.5% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before recovery.

8 years โ†‘ 1,847.43%

Pediatrix Medical continues its impressive multi-year expansion with a 8-year growth streak (1.75 โ†’ 34.08), delivering 1,847.4% cumulative returns. While annual revenue reaches 458.4M, net income of 20.7M (4.5% margin) in Qtr ending Mar 2025 shows the company prioritizes growth over margins - common for expanding Healthcare players.

8 years โ†‘ 1,018.73%

Andersons solidifies its market leadership with a 8-year growth streak (2.67 โ†’ 29.87), delivering 1,018.7% cumulative returns. With 2.7B annual revenue generating only 5.3M profit (0.2% margin) in Qtr ending Mar 2025, the market prices in significant margin expansion ahead.

5 years โ†“ -67.20%

La-Z-Boy endures extended market pressure with a 5-year decline (24.18 โ†’ 7.93), down 67.2% cumulatively. Weak margins on 570.9M annual revenue with only 15.4M profit (2.7% margin) in Qtr ending Apr 2025 validate market skepticism. Structural improvements needed before recovery.

4 years โ†“ -81.75%

Celldex Therapeutics faces prolonged challenges with a 4-year decline (493.20 โ†’ 90.00), down 81.8% cumulatively. Financial struggles compound yearly losses: despite 695,000 annual revenue, - 53.8M losses persist (-7740.4% margin) as of Qtr ending Mar 2025. Turnaround remains elusive.

United States Market Yearly Gainers & Losers: 2007

Top United States Stock Gainers (2007)

Stock Year Open Year Close Yearly Change Avg Daily Volume Year Volume
$1.93 $4.63 135.03% 194.3M 49.0B
$3.08 $7.07 133.33% 980.1M 247.0B
$9.95 $21.52 118.48% 34.5M 8.7B
$9.14 $15.67 72.01% 7.0M 1.8B
$11.66 $17.30 50.17% 216.5M 54.6B
$30.17 $267.14 795.24% 2.5M 625.9M
$21.61 $94.34 341.67% 2.8M 709.0M
$5.18 $22.01 329.04% 7.8M 2.0B
$10.78 $35.89 236.68% 9.2M 2.3B
$43.98 $114.86 163.38% 1.1M 286.7M
$4.58 $13.27 209.32% 750.7K 189.2M
$8.73 $24.42 187.97% 93.7K 23.6M
$18.48 $49.50 168.29% 1.4M 342.0M
$43.09 $113.40 166.26% 23.6M 6.0B
$1.26 $3.09 151.22% 114.8K 28.9M
$136.48 $939.33 588.25% 19.6K 4.9M
$0.87 $2.85 235.29% 100.3K 25.3M
$98.60 $273.40 178.70% 53.6K 13.5M
$6.28 $15.75 148.03% 114.6K 28.9M
$2.16 $5.35 147.69% 57.2K 14.4M

Biggest United States Stock Losers (2007)

Stock Year Open Year Close Yearly Change Avg Daily Volume Year Volume
$20.08 $7.50 -63.14% 26.7M 6.7B
$81.93 $53.11 -34.78% 10.0M 2.5B
$41.30 $26.94 -32.92% 18.4M 4.6B
$53.40 $41.26 -22.72% 22.5M 5.7B
$35.93 $30.19 -15.10% 17.1M 4.3B
$33.13 $10.54 -68.18% 4.6M 1.2B
$63.50 $20.64 -67.39% 5.9M 1.5B
$6.99 $2.30 -66.86% 1.9M 475.4M
$45.78 $15.47 -66.21% 57.3K 14.4M
$49.07 $17.03 -65.90% 4.3M 1.1B
$48.57 $5.76 -88.10% 555.7K 140.0M
$54.16 $11.68 -78.33% 2.5M 636.2M
$53.89 $14.71 -72.68% 2.7M 671.3M
$38.05 $10.50 -72.51% 284.9K 71.8M
$23.86 $7.28 -69.49% 1.7M 424.9M
$7.85 $2.77 -64.26% 82.8K 20.9M
$237.60 $90.00 -62.69% 1.3K 327.3K
$16.32 $6.06 -62.66% 385.4K 97.1M
$14.34 $5.90 -58.45% 6.1M 1.5B
$19.26 $8.46 -55.66% 80.5K 20.3M

Most Active United States Stocks During 2007

Stock Year Open Year Close Yearly Change Avg Daily Volume Yearly Volume
$3.08 $7.07 133.33% 980.1M 247.0B
$0.62 $0.85 37.10% 603.4M 152.1B
$11.66 $17.30 50.17% 216.5M 54.6B
$1.93 $4.63 135.03% 194.3M 49.0B
$29.91 $35.60 19.22% 62.1M 15.7B
$20.45 $26.66 31.65% 64.9M 16.4B
$3.86 $4.89 27.68% 59.0M 14.9B
$7.56 $6.73 -10.39% 45.5M 11.5B
$14.13 $9.13 -35.29% 44.9M 11.3B
$24.81 $21.57 -12.21% 40.1M 10.1B
$43.09 $113.40 166.26% 23.6M 6.0B
$5.81 $4.20 -27.59% 18.0M 4.5B
$9.28 $6.71 -27.54% 11.3M 2.8B
$6.34 $5.46 -13.47% 11.2M 2.8B
$9.56 $7.57 -20.15% 8.8M 2.2B
$7.50 $4.63 -38.02% 9.2M 2.3B
$14.34 $5.90 -58.45% 6.1M 1.5B
$15.96 $19.72 23.95% 5.8M 1.5B
$31.77 $20.77 -33.45% 3.9M 986.8M
$26.32 $15.40 -41.29% 2.4M 609.7M

United States Sector Performance During 2007

Basic Materials

25.54%
129 stocks
Top Performers by Market Cap:
Mega Cap: LIN +49.52%
Large Cap: MOS +341.67%
Small Cap: SA +108.50%

Energy

20.40%
107 stocks
Top Performers by Market Cap:
Mega Cap: CVX +26.93%
Large Cap: HES +103.47%
Small Cap: HP +63.75%

Utilities

16.24%
61 stocks
Top Performers by Market Cap:
Large Cap: NRG +54.79%
Mid Cap: ORA +49.40%
Small Cap: NWN +14.66%

Industrials

16.15%
351 stocks
Top Performers by Market Cap:
Mega Cap: GE -0.38%
Large Cap: J +134.50%
Small Cap: SBLK +588.25%

Healthcare

14.85%
278 stocks
Top Performers by Market Cap:
Mega Cap: ABT +15.28%
Large Cap: ISRG +236.68%
Small Cap: OPK +235.29%

Technology

10.96%
298 stocks
Top Performers by Market Cap:

Consumer Defensive

7.34%
107 stocks
Top Performers by Market Cap:
Mega Cap: COST +31.95%
Large Cap: BG +60.54%
Small Cap: FDP +125.22%

Communication Services

4.70%
77 stocks
Top Performers by Market Cap:
Mega Cap: GOOGL +50.17%
Large Cap: WBD +56.33%
Small Cap: IMAX +81.38%

Consumer Cyclical

-4.22%
258 stocks
Top Performers by Market Cap:
Mega Cap: AMZN +135.03%
Large Cap: BKNG +163.38%
Mid Cap: OI +168.29%
Small Cap: SG +15.00%

Financial Services

-13.41%
426 stocks
Top Performers by Market Cap:
Mega Cap: MA +118.48%
Large Cap: BAP +86.40%
Mid Cap: BGC +29.59%
Small Cap: FBMS +87.10%

Real Estate

-17.61%
117 stocks
Top Performers by Market Cap:
Large Cap: IRM +34.33%
Small Cap: DX +25.11%

Data is updated regularly. Yearly performance is calculated based on closing prices.